Related Experiment Video
Updated: Apr 5, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid
Abhirami K Iyer1, Jianyun Liu1, Richard M Gallo1
1Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
Abstract:
Cytokines that regulate the immune response signal through the Janus kinase / signal transducer and activation of transcription (JAK/STAT) pathway, but whether this pathway can regulate CD1d-mediated lipid antigen presentation to natural killer T (NKT) cells is unknown. Here, we found that STAT3 promotes antigen presentation by CD1d. Antigen-presenting cells (APCs) in which STAT3 expression was inhibited exhibited markedly reduced endogenous lipid antigen presentation to NKT cells without an impact on exogenous lipid antigen presentation by CD1d. Consistent with this observation, in APCs where STAT3 was knocked down, dramatically decreased levels of UDP glucose ceramide glucosyltransferase (UGCG), an enzyme involved in the first step of glycosphingolipid biosynthesis, were observed. Impaired lipid antigen presentation was reversed by ectopic expression of UGCG in STAT3-silenced CD1d(+) APCs. Hence, by controlling a fundamental step in CD1d-mediated lipid antigen presentation, STAT3 signalling promotes innate immune responses driven by CD1d.
Insights
Signal transducer and activator of transcription 3 (STAT3) promotes CD1d-mediated lipid antigen presentation. STAT3 regulates UDP glucose ceramide glucosyltransferase (UGCG), a key enzyme in glycosphingolipid biosynthesis, impacting innate immune responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Cytokines regulate immune responses via the Janus kinase/signal transducer and activation of transcription (JAK/STAT) pathway.
- The role of the JAK/STAT pathway in CD1d-mediated lipid antigen presentation to natural killer T (NKT) cells remains unclear.
Purpose of the Study:
- To investigate whether STAT3 signaling influences CD1d-mediated lipid antigen presentation to NKT cells.
- To elucidate the molecular mechanisms by which STAT3 might regulate this process.
Main Methods:
- Inhibition of STAT3 expression in antigen-presenting cells (APCs).
- Assessment of endogenous and exogenous lipid antigen presentation to NKT cells.
- Quantification of UDP glucose ceramide glucosyltransferase (UGCG) levels.
- Reversal of impaired antigen presentation via ectopic UGCG expression.
Main Results:
- STAT3 inhibition significantly reduced endogenous, but not exogenous, lipid antigen presentation by CD1d+ APCs.
- STAT3 knockdown led to decreased levels of UGCG, an enzyme crucial for glycosphingolipid biosynthesis.
- Restoring UGCG expression in STAT3-silenced cells rescued the defect in CD1d-mediated lipid antigen presentation.
Conclusions:
- STAT3 signaling is a key promoter of CD1d-mediated endogenous lipid antigen presentation.
- STAT3 controls glycosphingolipid biosynthesis by regulating UGCG, thereby modulating innate immune responses via NKT cells.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
IP3/DAG Signaling Pathway
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Lipid Catabolism
Regulation of Nuclear Protein Sorting

